Treatment of Drug-Susceptible Tuberculosis
Ann Am Thorac Soc
.
2016 Nov;13(11):2060-2063.
doi: 10.1513/AnnalsATS.201607-567CME.
Authors
Charles S Dela Cruz
1
,
Patrick G Lyons
2
,
Susan Pasnick
3
,
Tanya Weinstock
4
5
,
Payam Nahid
3
,
Kevin C Wilson
6
,
Carey C Thomson
4
5
Affiliations
1
1 Section of Pulmonary, Critical Care, and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut.
2
2 Section of Pulmonary and Critical Care Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois.
3
3 Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California.
4
4 Division of Pulmonary Disease and Critical Care Medicine, Mount Auburn Hospital, Cambridge, Massachusetts.
5
5 Harvard Medical School, Boston, Massachusetts; and.
6
6 Division of Allergy, Pulmonary, Critical Care, and Sleep Medicine, Boston University Medical Center, Boston, Massachusetts.
PMID:
27831799
DOI:
10.1513/AnnalsATS.201607-567CME
No abstract available
Publication types
Comment
MeSH terms
Antitubercular Agents*
Drug Resistance, Bacterial / drug effects
Humans
Mycobacterium tuberculosis / drug effects
Tuberculosis*
Tuberculosis, Multidrug-Resistant
Substances
Antitubercular Agents